Sunitinib | compare suppliers & send inquiries for free

Here you will find a list of producers, manufacturers and traders of Sunitinib. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

		GMP	CEP	DMF	FDA	WC	Available for download Document available for download after approval of supplier Set as available by supplier but document not uploaded yet
MSN Labs. MOQ: 0 kg Type: Producer Origin: India	MOQ 0 kg Producer	−	−		−	−	+ 0	Send inquiry Average reply < 4h
Mylan Type: Producer Origin: India	Producer		−		−		+ 0	Send inquiry Average reply > 1w
Shilpa Medicare Type: Producer Origin: India	Producer	−	−		−	−	+ 0	Send inquiry Average reply < 8h
Hetero Labs Type: Producer Origin: India	Producer		−	−	−		+ 0	Send inquiry Average reply > 1w
Teva Type: Producer Origin: Israel	Producer	−	−		−	−	+ 0	Send inquiry Average reply > 1w
Reliance Life Sciences Type: Producer Origin: India	Producer	−	−		−		+ 0	Send inquiry Average reply > 1w
Hunan Ouya Biological Co., Ltd. Type: Producer Origin: China	Producer	−	−	−	−	−	+ 0	Send inquiry Average reply > 1w
Qilu Antibiotics Type: Producer Origin: China	Producer	−	−	−	−		+ 0	Send inquiry Average reply > 1w
Beijing Lunarsun Pharma Type: Producer Origin: China	Producer	−	−	−	−	−	+ 0	Send inquiry Average reply > 1w
Medichem Manufacturing Type: Producer Origin: Malta	Producer	−	−		−	−	+ 0	Send inquiry Average reply > 1w
Adley Formulations Type: Producer Origin: India	Producer		−	−	−	−	+ 0	Send inquiry Average reply > 1w

Looking for Sunitinib 557795-19-4?

API | Excipient name:: Sunitinib
Synonyms:: Sunitinibum
Cas Number:: 557795-19-4
DrugBank number:: DB01268
Unique Ingredient Identifier:: V99T50803M

About Sunitinib

Why are people looking for Sunitinib? Sunitinib is a small-molecule multi-targeted receptor tyrosine kinase (RTK) inhibitor. On January 26, 2006, the agent was formally approved by the US FDA for the indications of treating renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST). For these purposes, sunitinib is generally available as an orally administered formulation. Sunitinib inhibits cellular signaling by targeting multiple RTKs.

These include all platelet-derived growth factor receptors (PDGF-R) and vascular endothelial growth factor receptors (VEGF-R). Sunitinib also inhibits KIT (CD117), the RTK that drives the majority of GISTs. In addition, sunitinib inhibits other RTKs including RET, CSF-1R, and flt3.

Not sure if this is the exact product you're looking for? Contact the supplier by using the send inquiry button.

Sunitinib manufacturers | traders | suppliers
We have 11 companies offering Sunitinib from 3 different countries.

Get in contact with the supplier of your choice:

MSN Labs. from India
Shilpa Medicare from India
Mylan from India
Hetero Labs from India
Teva from Israel
Reliance Life Sciences from India
Medichem Manufacturing from Malta
Adley Formulations from India
Qilu Antibiotics from China
Beijing Lunarsun Pharma from China
Hunan Ouya Biological Co., Ltd. from China

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.